NEW YORK, Aug. 03, 2026 (GLOBE NEWSWIRE) — Vornado Realty Trust (NYSE: VNO) reported today: Quarter Ended June 30, 2026 Financial Results NET INCOME attributable to common shareholders for the quarter ended June 30, 2026 was $16,434,000, or $0.08 per diluted share, compared to $743,819,000, or $3.70 per diluted share, for the prior year’s quarter. The decrease is primarily due to the $803,248,000 gain related to the 770 Broadway master lease with New York University (“NYU”) during the three months ended June 30, 2025. FUNDS FROM OPERATIONS (“FFO”) attributable to common shareholders plus assumed conversions (non-GAAP) for the quarter ended June 30, 2026 was $144,078,000, or $0.74 per diluted share, compared to $120,928,000, or $0.60 per diluted share, for the prior year’s quarter. Adjusting...

ONEOK achieves record NGL raw feed throughput volumes, driven by a 15% increase in the Gulf Coast/Permian region in second quarter 2026 compared with second quarter 2025.ONEOK, Inc.ONEOK mechanically completed its refined products pipeline expansion connecting Mid-Continent and Gulf Coast supply to the Greater Denver area and Denver International Airport.ONEOK, Inc.Record NGL Raw Feed Throughput Volumes ONEOK Increases 2026 Financial Guidance TULSA, Okla., Aug. 03, 2026 (GLOBE NEWSWIRE) — ONEOK, Inc. (NYSE: OKE) today announced higher second-quarter 2026 results and increased 2026 financial guidance. Unless otherwise noted, all results are compared with the same period in 2025. Highlights:Higher second-quarter 2026 results:13% increase in net income to $967 million, resulting in $1.53 per diluted share 7%...

Exceptional Order Intake and Increasing Market Share Drive Sequential Backlog Growth of 121% Aftermarket Revenue Growth of 13% Year over Year; Second Aftermarket Acquisition Completed Following Quarter End Operating Cash Flow of $12.1 Million and Free Cash Flow of $11.3 Million, Up 43% Year over Year CHICAGO, Aug. 03, 2026 (GLOBE NEWSWIRE) — FreightCar America, Inc. (NASDAQ: RAIL) (“FreightCar America” or the “Company”), a diversified manufacturer and supplier of railroad freight cars, railcar parts and components, today reported results for the second quarter ended June 30, 2026. Second Quarter 2026 HighlightsRevenues of $113.1 million, compared to $118.6 million in the second quarter of 2025, with railcar deliveries of 927 units compared to 939 units in the prior year period Aftermarket revenues grew 13% year over year, reflecting...

ZUG, Switzerland and BOSTON, Aug. 03, 2026 (GLOBE NEWSWIRE) — CRISPR Therapeutics (Nasdaq: CRSP) today reported financial results for the second quarter ended June 30, 2026. “The second quarter reflected strong execution across CRISPR Therapeutics’ portfolio and platform,” said Samarth Kulkarni, Ph.D., Chairman and Chief Executive Officer of CRISPR Therapeutics. “CASGEVY’s momentum continued to build, highlighted by the FDA’s approval for children as young as 2 years old, while we expanded our in vivo pipeline with the initiation of Phase 1 clinical trials for CTX340 for refractory hypertension and CTX460 for alpha-1 antitrypsin deficiency. We enter the second half of 2026 well positioned, with a number of important milestones ahead across our pipeline.” Recent Highlights and Outlook Hemoglobinopathies...

ROCK HILL, S.C., Aug. 03, 2026 (GLOBE NEWSWIRE) — 3D Systems Corporation (NYSE:DDD) announced today its financial results for the second quarter ended June 30, 2026.Q2 2026 revenue of $94.6 million, down 0.3% year-over-year, but up 1.4% excluding divestitures, driven by continued acceleration of new printer sales, with double-digit growth in both metal and polymer hardware printer systems. Net loss was $(12.9) million for the quarter, while Adjusted EBITDA improved to a loss of $(0.8) million, reflecting benefits from previous cost reduction initiatives. For the first half of 2026, the Company reported a net loss of $(17.3) million and positive Adjusted EBITDA of $1.3 million. Healthcare continued as the Company’s largest segment in the quarter, with revenue increasing 6.8% year-over-year, supported by over 20% growth in...

BRANFORD, Conn., Aug. 03, 2026 (GLOBE NEWSWIRE) — Sachem Capital Corp. (NYSE American: SACH) (the “Company”) announced today that the Company will release its second quarter 2026 financial results after market close on Wednesday, August 5, 2026. The release will also provide an update on the pending asset contribution transaction with Industrial Realty Group (IRG). The transaction is valued at approximately $1.5 billion, and the combined entity, to be renamed IRG Realty Trust (IRGT), should emerge as a top-10 publicly listed industrial REIT with an implied enterprise value of about $3.4 billion. About Sachem Capital Corp. Sachem is a mortgage REIT that specializes in originating, underwriting, funding, servicing, and managing a portfolio of loans secured by first mortgages on real property. It offers short-term (i.e., one to three...

Delivered ~15% WW revenue growth and ~178% increase in adjusted EBITDA ~19% increase in U.S. physician base Second Quarter 2026 Financial Highlights (all comparisons are to the prior year period)Worldwide revenue of $56.0 million, representing growth of 15.2% U.S. revenue of $53.2 million, representing growth of 14.7% Gross margin of 79.5% Net loss of $4.1 million, representing an improvement of 33.6% Positive adjusted EBITDA of $2.8 million, an improvement of 178.0% Positive cash from operations of $0.8 million $145.9 million in cash and equivalents, representing a sequential increase of $1.3 millionRecent Operational Highlights (any comparisons are to the prior year period)1,715 active U.S. physicians, representing growth of 19% $2.2 million in trailing 12-month average revenue per territory, representing an increase of 5% In...

HOUSTON, Aug. 03, 2026 (GLOBE NEWSWIRE) — Powell Industries, Inc. (NASDAQ: POWL) (“Powell” or the “Company”), a leading supplier of custom-engineered solutions for the management, control and distribution of electrical energy, today announced results for the third quarter Fiscal 2026 ended June 30, 2026. All comparisons are to the third quarter of Fiscal 2025, unless otherwise noted. Key Highlights: Revenues of $312 million increased 9%; Gross profit of $95 million, or 30.6% of revenue, increased 8%; Net income of $52 million, or $1.42 per diluted share(1), increased 8%; New orders(2) totaled $934 million, an increase of 158%; Backlog(3) as of June 30, 2026 totaled $2.4 billion, an increase of 69%; Cash and short-term investments as of June 30, 2026 totaled $634 million; Powell was awarded three mega(4) orders during the fiscal...

Q2 Revenue grew 113% year-over-year to $190 million Q2 Direct Channel Revenue grew 131% year-over-year to $116 million Q2 Third-Party Revenue grew 90% year-over-year to $73 million Board of Directors authorized a share repurchase program of up to $100 million of Ethos’ Class A common stockAUSTIN, Texas, Aug. 03, 2026 (GLOBE NEWSWIRE) — Ethos (Nasdaq: LIFE), a leading life insurance technology company on a mission to democratize access to life insurance, today announced its financial results for the second quarter ended June 30, 2026. “Q2 was our second consecutive quarter of over 100% year-over-year growth, extending a streak of durable, multi-year growth we’ve built quarter over quarter,” said Peter Colis, CEO and Co-Founder of Ethos. “In Q2 alone, we protected more than 100,000 additional families at...

      Announced Vertex Agreement to Acquire Crinetics for Total Equity Value of Approximately $10.0 Billion, or Approximately $8.8B Net of Estimated Cash Acquired       PALSONIFY® (Paltusotine) Net Product Revenue of $24.0 Million for Second-Quarter 2026 SAN DIEGO, Aug. 03, 2026 (GLOBE NEWSWIRE) — Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a global pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for endocrine diseases and endocrine-related tumors, today reported financial results for the second quarter ended June 30, 2026. Company Announcements and Second Quarter Highlights:On July 6, 2026, Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and Crinetics announced that the companies have entered into a definitive agreement under which Vertex will acquire Crinetics...